These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30306811)

  • 1. Potential pharmacobezoar formation of large size extended-release tablets and their dissolution - an in vitro study.
    Hoegberg LCG; Refsgaard F; Pedersen SH; Personne M; Ullah S; Panagiotidis G; Petersen TS; Annas A
    Clin Toxicol (Phila); 2019 Apr; 57(4):271-281. PubMed ID: 30306811
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Li YK; Lam KF; Wong CLW; Wong A
    Clin Toxicol (Phila); 2020 Sep; 58(9):900-906. PubMed ID: 31875726
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastric pharmacobezoars in quetiapine extended-release overdose: a case series.
    Rauber-Lüthy C; Hofer KE; Bodmer M; Kullak-Ublick GA; Kupferschmidt H; Ceschi A
    Clin Toxicol (Phila); 2013 Dec; 51(10):937-40. PubMed ID: 24199644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
    Hamed R; AlJanabi R; Sunoqrot S; Abbas A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic removal of a gastric pharmacobezoar induced by clomipramine, lorazepam, and domperidone overdose: a case report.
    von Düring S; Challet C; Christin L
    J Med Case Rep; 2019 Feb; 13(1):45. PubMed ID: 30808405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
    Kulinowski P; Woyna-Orlewicz K; Rappen GM; Haznar-Garbacz D; Węglarz WP; Dorożyński PP
    Int J Pharm; 2015 Apr; 484(1-2):235-45. PubMed ID: 25701626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
    Darwish M; Bond M; Tracewell W; Robertson P; Yang R
    Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Oct; 18(7):2394-2409. PubMed ID: 28138820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended release potassium salts overdose and endoscopic removal of a pharmacobezoar: A case report.
    Guillermo PTJ; Carlos PHJ; Ivonne BAM; Herminio TF; Rubén RP
    Toxicol Rep; 2014; 1():209-213. PubMed ID: 28962240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release drugs in overdose. Clinical considerations.
    Buckley NA; Dawson AH; Reith DA
    Drug Saf; 1995 Jan; 12(1):73-84. PubMed ID: 7741985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tableting of hot-melt coated paracetamol granules: Material tableting properties and quality characteristics of the obtained tablets.
    Milanovic A; Aleksic I; Ibric S; Parojcic J; Cvijic S
    Eur J Pharm Sci; 2020 Jan; 142():105121. PubMed ID: 31669762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal overdose with relapsing clomipramine concentrations due to a large gastric pharmacobezoar.
    Magdalan J; Zawadzki M; Słoka T; Sozański T
    Forensic Sci Int; 2013 Jun; 229(1-3):e19-22. PubMed ID: 23570967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
    Eisenhauer TD; Matchett M; Heasley R; Morton T; Devarakonda K; Giuliani M; Young JL; Barrett T
    Drug Dev Ind Pharm; 2016 Jan; 42(1):157-165. PubMed ID: 26146769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualizing of paracetamol immediate release tablet disintegration in vivo and in vitro.
    Fredholt F; Di Meo C; Sloth S; Müllertz A; Berthelsen R
    Eur J Pharm Biopharm; 2022 Nov; 180():63-70. PubMed ID: 36122785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic effects of endoscopic gastric decontamination for multidrug gastric pharmacobezoars.
    Marano M; Goffredo BM; Faraci S; Torroni F; Gowda SH; Perdichizzi S; Di Nardo M
    Toxicol Rep; 2024 Dec; 13():101683. PubMed ID: 39027424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].
    Mayer D; Raschack M; Kesselring K
    Arzneimittelforschung; 1975 Aug; 25(8):1272-5. PubMed ID: 241362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.